616 related articles for article (PubMed ID: 26146906)
1. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
[TBL] [Abstract][Full Text] [Related]
2. A role for calmodulin-stimulated adenylyl cyclases in cocaine sensitization.
DiRocco DP; Scheiner ZS; Sindreu CB; Chan GC; Storm DR
J Neurosci; 2009 Feb; 29(8):2393-403. PubMed ID: 19244515
[TBL] [Abstract][Full Text] [Related]
3. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
Itzhak Y; Gandia C; Huang PL; Ali SF
J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
[TBL] [Abstract][Full Text] [Related]
4. Investigation of calcium-stimulated adenylyl cyclases 1 and 8 on toluene and ethanol neurobehavioral actions.
Conti AC; Lowing JL; Susick LL; Bowen SE
Neurotoxicol Teratol; 2012; 34(5):481-8. PubMed ID: 22789433
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats.
Chen PC; Chen JC
Neuropsychopharmacology; 2005 Mar; 30(3):538-49. PubMed ID: 15536496
[TBL] [Abstract][Full Text] [Related]
6. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
Igari M; Shen HW; Hagino Y; Fukushima S; Kasahara Y; Lesch KP; Murphy DL; Hall FS; Uhl GR; Ikeda K; Yaegashi N; Sora I
Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
[TBL] [Abstract][Full Text] [Related]
8. Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice.
Chien CC; Lee YJ; Fan LW; Ho IK; Tien LT
Toxicol Lett; 2012 Jul; 212(1):61-5. PubMed ID: 22564758
[TBL] [Abstract][Full Text] [Related]
9. Comparison between the role of the neuronal and inducible nitric oxide synthase in methamphetamine-induced neurotoxicity and sensitization.
Itzhak Y; Martin JL; Ali SF
Ann N Y Acad Sci; 2000 Sep; 914():104-11. PubMed ID: 11085313
[TBL] [Abstract][Full Text] [Related]
10. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
11. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
[TBL] [Abstract][Full Text] [Related]
12. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.
Park SW; Shen X; Tien LT; Roman R; Ma T
J Biomed Sci; 2011 Nov; 18(1):83. PubMed ID: 22074218
[TBL] [Abstract][Full Text] [Related]
14. Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty.
Fujikawa A; Noda Y; Yamamoto H; Tanga N; Sakaguchi G; Hattori S; Song WJ; Sora I; Nabeshima T; Katsuura G; Noda M
PLoS One; 2019; 14(8):e0221205. PubMed ID: 31430310
[TBL] [Abstract][Full Text] [Related]
15. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
Yun J
Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791
[TBL] [Abstract][Full Text] [Related]
16. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice.
Mizoguchi H; Yamada K; Niwa M; Mouri A; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
J Neurochem; 2007 Mar; 100(6):1579-88. PubMed ID: 17348864
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
18. Aberrant behavioral sensitization by methamphetamine in junctophilin-deficient mice.
Moriguchi S; Nishi M; Sasaki Y; Takeshima H; Fukunaga K
Mol Neurobiol; 2015 Apr; 51(2):533-42. PubMed ID: 24848513
[TBL] [Abstract][Full Text] [Related]
19. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants.
Corvol JC; Valjent E; Pascoli V; Robin A; Stipanovich A; Luedtke RR; Belluscio L; Girault JA; Hervé D
Neuropsychopharmacology; 2007 May; 32(5):1109-21. PubMed ID: 17063155
[TBL] [Abstract][Full Text] [Related]
20. The role of striatal Gα
Lee KW; Kim K; Kim HC; Lee SY; Jang CG
Behav Brain Res; 2018 Jul; 346():66-72. PubMed ID: 29223637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
